Skip to content

TuHURA Biosciences, Inc./NV

HURA

CIK 0001498382 · Pharmaceutical Preparations · Nasdaq

  • Kintara Therapeutics, Inc. (until 2024-10-22)
  • DelMar Pharmaceuticals, Inc. (until 2020-08-18)
  • Berry Only Inc. (until 2013-01-18)
← back to feed
Revenue (TTM)
$0
Q1 May 2026
Net Income (TTM)
−$30.83M
−38.6% YoY Q1 May 2026
EPS Diluted (TTM)
−$0.63
+47.9% YoY Q1 May 2026
Gross Margin
—
Q1 May 2026
Operating Margin
—
Q1 May 2026
Net Margin
—
Q1 May 2026
Free Cash Flow (TTM)
−$14.95M
Q1 May 2026
Cash
$6.3M
Q1 May 2026
Total Debt
$248.7K
Q1 May 2026
Shares Outstanding
63.68M sh
Q1 May 2026

Revenue & Net Income

EPS (Diluted)

Cash Flow

Revenue Growth (YoY)

No data available for this metric.

Balance Sheet

Cash vs Debt

Recent filings